Showing results (21-30 of 575) with videos related to
Sort By:
Pageof 58
Advances in Experimental Medicine and Biology|January 1, 1977
New approaches in the management of hyperkinetic movement disordersS FahnBiochimica Et Biophysica Acta|July 20, 1981
L-DOPA (L-3,4-dihydroxyphenylalanine) uptake by human red blood cellsA Floud, S FahnAnnals of Neurology|December 1, 1992
The oxidant stress hypothesis in Parkinson's disease: evidence supporting itS Fahn, G CohenMovement Disorders : Official Journal of the Movement Disorder Society|January 1, 1991
Hereditary essential myoclonus in a large Norwegian familyS Fahn, O SjaastadMovement Disorders : Official Journal of the Movement Disorder Society|January 1, 1994
A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet in Parkinson's diseaseC W Olanow, S Fahn, M Muenter, et al.Journal of Neural Transmission. Supplementum|January 1, 1980
Unilateral Parkinson's disease and contralateral tardive dyskinesia: a unique case with successful therapy that may explain the pathophysiology of these two disordersS Fahn, R MayeuxAnnals of Neurology|September 1, 1982
3-O-methyldopa blocks dopa metabolism in rat corpus striatumA Reches, S FahnAdvances in Neurology|January 1, 1984
Catechol-O-methyltransferase and Parkinson's diseaseA Reches, S FahnNeurology|October 1, 1982
Paroxysmal dystonic choreoathetosis in a patient with familial ataxiaR Mayeux, S FahnPageof 58